RNA sequencing of S. Cerevisiae treated with the Vacuolar H+-ATPase inhibitor concanamycin A (concA)

RNA sequencing results identifying transcript abundance changes that occur after treating budding yeast with V-ATPase inhibitors Overall design: Wild type BY4741 were treated with the V-ATPase inhibitor concA for 0, 1, 3, or 6 hours in triplicate followed by RNA purification and single read RNA sequencing.